Search
for

    Did you mean Hair Follicle Induction?
    GlossaryHair Follicle Induction

    process forming new hair follicles through cell interactions

    Hair Follicle Induction refers to the process by which new hair follicles are formed, typically through the interaction of specific cells and signaling pathways in the skin. This process is crucial for hair growth and regeneration, and it involves the activation of stem cells and the coordination of molecular signals that guide the development of new follicles.

    Related Terms

    Learn

    5 / 52 results

      learn Microneedling

      technique to create small wounds in skin to activate collagen production and hair growth

      learn KY19382

      compound that activates Wnt/β-catenin to promote hair regrowth and create new hair follicles

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community Results of Procyanidin B2 in clinical studies

      in Treatment  13 upvotes 5 years ago
      Procyanidin B2, a compound derived from Annurca apples, as a potential treatment for pattern hair loss. Several clinical studies were mentioned, which found that procyanidin B2 could increase hair growth, density, and keratin content. Other treatments such as Minoxidil, Finasteride, and RU58841 were not discussed.

      community The mechanism of androgenic alopecia

      in Research/Science  33 upvotes 5 months ago
      DHT may inhibit hair growth by affecting mitochondrial function, leading to hair follicle miniaturization. Treatments like minoxidil and PP405 may promote hair growth by altering metabolic pathways, potentially counteracting DHT's effects.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.